N20.0

Calculus of kidney

## Clinical Overview of Nephrolithiasis (Calculus of Kidney) Nephrolithiasis, specifically designated as calculus of the kidney (N20.0), refers to the presence of solid crystalline deposits within the renal parenchyma or the renal collecting system (calyces and renal pelvis). These stones, or calculi, develop when the urinary concentrations of specific solutes—most commonly calcium, oxalate, and uric acid—exceed their solubility limit within the urine, a state known as supersaturation. This condition is a significant cause of morbidity in the general population, with a lifetime prevalence of approximately 10-12% in males and 5-6% in females. ### Pathophysiology and Composition The formation of kidney stones is a complex biochemical process involving nucleation, crystal growth, and aggregation. The most common stone type is calcium oxalate (75-80%), which often forms in a background of hypercalciuria or hyperoxaluria. Other types include calcium phosphate, uric acid (associated with acidic urine pH), struvite (magnesium ammonium phosphate, typically associated with urease-producing bacteria like Proteus), and cystine (resulting from rare genetic transport defects). Supersaturation is the primary driver, often exacerbated by low urine volume, high dietary sodium, or metabolic abnormalities such as hypocitraturia. Citrate is a critical natural inhibitor of stone formation as it complexes with calcium, reducing the amount of free calcium available to bind with oxalate. ### Clinical Presentation and Diagnosis Stones confined to the kidney (N20.0) may remain asymptomatic for years if they are non-obstructing. However, they can cause a dull, persistent flank ache or microscopic hematuria. If a stone becomes large enough to cause hydronephrosis within the kidney or migrates toward the ureteropelvic junction, it can cause severe, sharp pain. The gold standard for diagnosis is a non-contrast computed tomography (NCCT) of the abdomen and pelvis. NCCT allows for the assessment of stone size, location, and density (measured in Hounsfield units), which provides prognostic information regarding the likelihood of spontaneous passage or the success of lithotripsy. Ultrasonography is utilized as a secondary modality, particularly in pediatric and pregnant populations, to minimize radiation exposure. ### Management and Prevention Acute management focuses on pain control (typically with NSAIDs or opioids) and assessing the need for intervention. Stones smaller than 5mm have a high probability of spontaneous passage. Larger stones or those causing intractable pain, infection, or renal failure require surgical intervention. Standard procedures include Extracorporeal Shock Wave Lithotripsy (ESWL), Ureteroscopy (URS) with laser fragmentation, or Percutaneous Nephrolithotomy (PCNL) for stones larger than 2cm (such as staghorn calculi). Long-term management involves metabolic evaluation via 24-hour urine collection to identify reversible risk factors. Preventive strategies emphasize high fluid intake (target >2.5L urine/day), dietary sodium restriction, and specific pharmacotherapy like thiazide diuretics for hypercalciuria or potassium citrate for hypocitraturia.

Clinical Symptoms

  • Dull flank pain
  • Hematuria (microscopic or gross)
  • Nausea and vomiting
  • Renal colic (paroxysmal severe pain)
  • Frequent urination
  • Urinary urgency
  • Pyuria (white blood cells in urine)
  • Recurrent urinary tract infections (UTIs)
  • Abdominal tenderness

Common Causes

  • Dehydration (low fluid intake)
  • Hypercalciuria (excess calcium in urine)
  • Hyperoxaluria (excess oxalate in urine)
  • Hyperuricosuria (excess uric acid in urine)
  • Hypocitraturia (low citrate levels in urine)
  • High dietary sodium intake
  • High intake of animal proteins
  • Hyperparathyroidism
  • Obesity and metabolic syndrome
  • Medullary sponge kidney
  • Renal tubular acidosis (Type 1)
  • Cystinuria (genetic disorder)

Documentation & Coding Tips

Document Laterality and Specific Location within the Kidney

Example: Patient presents with a 6mm stone in the lower pole of the left kidney (N20.0). Plan includes monitoring and hydration. Laterality is confirmed as left to support surgical site verification and billing specificity.

Billing Focus: Documentation must specify whether the calculus is in the left, right, or both kidneys to ensure accurate ICD-10-CM code selection.

Distinguish Between Kidney and Ureteral Calculus

Example: CT scan confirms an 8mm calculus in the right renal pelvis (N20.0), with no current descent into the ureter. If the stone moves to the ureter, the code would change to N20.1.

Billing Focus: Accurate site identification prevents miscoding between N20.0 (Kidney) and N20.1 (Ureter), which are distinct anatomical codes.

Specify Presence or Absence of Obstruction and Hydronephrosis

Example: Patient has a right-sided renal calculus (N20.0) with associated moderate hydronephrosis (N13.2). Chronic Kidney Disease Stage III (N18.30) is present and potentially exacerbated by this obstruction.

Billing Focus: If hydronephrosis is present with calculus, the combination code N13.2 should be prioritized over N20.0 to capture the full clinical picture.

Identify Complicating Infections

Example: Diagnosis of left renal calculus (N20.0) complicated by acute obstructive pyelonephritis (N13.6). Patient is septic (A41.9) and requires emergent decompression via stent placement.

Billing Focus: Infection status triggers more complex DRG assignments in inpatient settings and requires coding for both the calculus and the infection.

Note Morphology such as Staghorn Calculus

Example: Patient exhibits a large, branched staghorn calculus (N20.0) filling the right renal pelvis and calyces. This requires percutaneous nephrolithotomy (PCNL) due to size and location.

Billing Focus: While N20.0 covers staghorn stones, the term 'Staghorn' should be documented to justify high-complexity procedural interventions.

Link Chronic Conditions and Metabolic Factors

Example: Nephrolithiasis (N20.0) in a patient with Type 2 Diabetes (E11.9) and Secondary Hyperparathyroidism (E21.1). Management includes dietary modification to reduce calcium oxalate formation.

Billing Focus: Coding the underlying metabolic cause (e.g., hypercalcemia) alongside the stone captures the complete etiology.

Relevant CPT Codes

Related Diagnoses

Hierarchy